Nanochon Overview

  • Founded
  • 2013

Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $1.8M

  • Investors
  • 16

Nanochon General Information

Description

Developer of medical devices and other technology intended to treat joint injuries and diseases. The company's devices replace lost and damaged cartilage and encourage new tissue growth, enabling medical practitioners to get access to cost-effective and on-demand devices that improve outcomes in young and active patients with knee damage.

Contact Information

Website
www.nanochon.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Commercial Products
Primary Office
  • 7144 13th Place North West
  • Suite 2200
  • Washington, DC 20012
  • United States

Nanochon Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanochon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Seed Round 15-Aug-2023 $1.8M 00.000 000.00 Completed Clinical Trials - Phase 1
10. Grant 01-Nov-2022 0000 00.000 Completed Pre-Clinical Trials
9. Seed Round 01-Jul-2022 00000 00.000 00.00 Completed Pre-Clinical Trials
8. Seed Round 01-Oct-2021 00.000 00.000 00.00 Completed Pre-Clinical Trials
7. Accelerator/Incubator 15-May-2019 Completed Pre-Clinical Trials
6. Accelerator/Incubator 22-Jun-2018 Completed Pre-Clinical Trials
5. Grant 11-Jul-2017 00000 Completed Pre-Clinical Trials
4. Accelerator/Incubator 01-Jun-2017 Completed Startup
3. Accelerator/Incubator 14-Oct-2016 Completed Startup
2. Grant 30-Sep-2016 $50K Completed Startup
To view Nanochon’s complete valuation and funding history, request access »

Nanochon Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed Prime 00,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Seed Preferred 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view Nanochon’s complete cap table history, request access »

Nanochon Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of medical devices and other technology intended to treat joint injuries and diseases. The company's devices r
Therapeutic Devices
Washington, DC
9 As of 2023
00.000
00.00 0000-00-00
000000000 00.000

000000

xercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute i
00000000000 0000000
Kfar Saba, Israel
00 As of 0000
000.00
0000 0000-00-00
000000&0 000.00

00000

magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris
00000000000 0000000
Bedford, MA
000 As of 0000
00.00
000000000000 00.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nanochon Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CartiHeal Formerly VC-backed Kfar Saba, Israel 00 000.00 000000&0 000.00
00000 000000000000 Formerly VC-backed Bedford, MA 000 00.00 000000000000 00.00
0000000 Private Equity-Backed Naples, FL 0000 00000 0000000 0000 00000
0000000 Corporation Ann Arbor, MI 000 00000 00000000 00000
000000 000000 Corporation Warsaw, IN 00000 000.00 000000000 00 000.00
You’re viewing 5 of 5 competitors. Get the full list »

Nanochon Patents

  • 6

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

Nanochon Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3829663-A4 Implantable scaffolds and uses thereof Pending 30-Jul-2018 000000000 0
US-20210298908-A1 Implantable scaffolds and uses thereof Pending 30-Jul-2018 000000000 0
EP-3829663-A1 Implantable scaffolds and uses thereof Pending 30-Jul-2018 000000000
US-20210022871-A1 Three-dimensionally printed tissue engineering scaffolds for tissue regeneration Pending 07-Aug-2016 000000000
US-20180055643-A1 Three-dimensionally printed tissue engineering scaffolds for tissue regeneration Active 07-Aug-2016 A61F2/30942
To view Nanochon’s complete patent history, request access »

Nanochon Executive Team (5)

Name Title Board Seat Contact Info
Benjamin Holmes Ph.D Co-Founder, Chief Executive Officer & Board Member
Matthew Scherer Chief Financial Officer & Advisor
Nathan Castro Ph.D Co-Founder & Chief Technology Officer
You’re viewing 3 of 5 executive team members. Get the full list »

Nanochon Board Members (5)

Name Representing Role Since
Benjamin Holmes Ph.D Nanochon Co-Founder, Chief Executive Officer & Board Member 000 0000
Gregory Horner Self Board Member 000 0000
Kurt Jacobus Nanochon Board Member 000 0000
Nicholas Pachuda Self Board Member 000 0000
Robert Creeden Self Board Member 000 0000
To view Nanochon’s complete board members history, request access »

Nanochon Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nanochon Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Johnson & Johnson Innovation - JJDC Corporate Venture Capital Minority 000 0000 000000 0
Kyto Technology And Life Science Corporation Minority 000 0000 000000 0
Mountain State Capital Venture Capital Minority 000 0000 000000 0
Asimov Ventures Venture Capital Minority 000 0000 000000 0
BICO Group Corporation Minority 000 0000 000000 0
You’re viewing 5 of 16 investors. Get the full list »

Ready to get started?

Request a free trial